Both she and CDC Semos mentioned orally and over email how pleased they were with the work I had done, and both expressed their eagerness to help. Pasquarelli, CDC Semos, and later numerous others including people in FBI management all reviewed the entire process I had been engaged in and not a single pe

AC was eventually briefed. A few days after the VCAC PCOR conference I heard from Joanna Pasquarelli who is an Ccncral Att rncy (Ct) for OGC. `GA—Pasquarelli attended the VCAC PCOR conference and saw my presentation. IIILGA—Pas quarelli informed me we needed to stop testing Apostlex immediately. She did